Abstract: Background: Deficits in cholinergic neurotransmission due to the degeneration of cholinergic neurons in the brain are believed to be one of the major causes of the memory impairments associated with AD. Targeting acetyl cholinesterase (AChE) surfaced as a potential therapeutic target in the treatment of Alzheimer's disease. The present study is pursued to develop quantitative structure activity relationship (QSAR) models to determine chemical descriptors responsible for AChE activity.
INTRODUCTION
Alzheimer's disease (AD) is one of the most dreaded forms of progressive neurodegenerative disorder of the modern era. It is associated with cognitive, functional and behavioral impairments which affect the brain regions that control thought, memory and language leading to a devastating status affecting predominantly elderly people. Alzheimer's disease (AD) and other forms of dementia are growing public health problems in developing countries, whose aging population is increasing rapidly [1] . It is estimated that by the year 2020, approximately 70% of the world's population aged 60 and above will suffer with Alzheimer's in developing countries [2] [3] [4] [5] .
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However, the precise cause of AD at the molecular grounds remains enigmatic, deficits in cholinergic neurotransmission due to the degeneration of cholinergic neurons in the brain are believed to be one of the major causes of the memory impairments associated with AD [6] [7] [8] . During the course of the normal aging process, concentrations of ACh tend to decrease, resulting in the sporadic lapses of shortterm memory that elderly individuals tend to experience from time to time [9] . Since cholinergic transmission is prominently involved in human memory system, AChE is a potential pharmacological target for treatment of AD.
Although there is no complete cure for Alzheimer's, there are two drugs presently marketed which inhibit acetyl cholinesterase -the enzyme which inactivates AChE at the synapse. Tetrohydroaminoacridine (THA), marketed in 1993, under the name Tacrine or Cognex, was the first Alzheimer's drug to be approved by the USFDA and has been shown to improve memory and language deficits in early stages of the disease [10] . A second drug, Donepezil was approved by the FDA in 1996, marketed under the name Aricept that targets only ACh in the brain and allows for the same improvements in cognitive function as THA [11] . Although these drugs helps to ease some of the symptoms of the disease, nevertheless have narrow therapeutic window and suffer side effects like lack of the drug's substrate specificity [12] [13] [14] . In the view of the given problem, the scientific team around the globe put forth active compounds targeting AchE anticipating for better management of Alzheimer's disease.
The present study focuses on building linear MLR and non-linear Gaussian kernel aided SVM QSAR models from two datasets which structurally belong to different scaffold and are derived from two different schemes of synthesis. The synthesis of derivatives was aimed to explore new candidates which can inhibit AChE more efficiently towards AD treatment. Few molecules among newly synthesized derivatives appeared promising when evaluated in vitro and effectively inhibited AChE. We aim to derive common structure-activity relationship from two different datasets through QSAR models which could assist to understand the overlapping structural features towards minimum chemical structure requirement to inhibit AChE in AD treatment.
MATERIALS AND METHODS

Selection of Compound Dataset
The first dataset includes 1,2,3,4-tetrahydroisoquinoline derivative (30 molecules) synthesized by N. Toda and colleagues [15] . The second dataset involved Galantamine, Tacrine and 18 coumarin-tacrine hybrids synthesized and evaluated by Qi Sun et al. [16] . These two sets of compounds were subjected to MLR (Linear) and SVM (Nonlinear) QSAR studies to derive individual QSAR models for each set and finally extract common chemical structure features responsible for structure-activity relationship (SAR) with reference to their action on AchE as a therapeutic target.
Calculation of Molecular Descriptor & Preparation of QSAR Model
The structures of compounds from each series were drawn and optimized in Chem Axon -Marvin Sketch version 5.6.0.2 [17] . The descriptors were calculated using an online web server E-Dragon (version 5.4) [18] [19] [20] . More than 2000 descriptors belonging to various classes were further analyzed by data analysis package of Graphpad Prism 6 for MLR analysis and for non-linear SVM analysis, GIST server was employed [21] . All the generated descriptors were further screened to establish valid models. In the process, constant and missing set of descriptors which were considered insignificant in statistical analysis were pruned (pruning parameters; standard deviation ≤0, and missing values greater than equal to 1) [22] . Pearson's correlation coefficient was used to establish correlation between molecular descriptors and biological responses (endpoints). Odds of redundancy in regression models were thoroughly inspected and removed using correlation matrix [23] . Forward selection wrappers were used to generate MLR [24] and non-linear QSAR [22] models. The SAR models thus obtained were validated using internal validation statistics like cross validated regression analysis, mean and maximum absolute error calculations.
RESULTS AND DISCUSSION
Statistical Fitness and Stability of QSAR Models
The present QSAR studies are an attempt to extract common SAR from two different sets of synthesized compounds tested against human AChE targeted in Alzheimer's disease. Two statistical methods, Multiple Linear Regression (MLR) and Support Vector Machine (SVM), have been used to achieve QSAR models. Gaussian Kernel function was used to obtain non-linear QSAR models in SVM. Table 1 provided below represents selected descriptors in multivariable models respectively for dataset-I and dataset-II. QSAR models obtained from forward selection method show uni-variable to tetra-variable models separately for dataset-I and dataset-II. The variable selection has been achieved under thumb-rule criteria which states that maximum descriptor variables cannot exceed 1/5 of total samples (compounds) in dataset. Dataset-I includes 30 molecules allows to exceed till hexa-variable model, though we decided to limit our models to tetra-variable model as it has gained necessary statistical fitness thereby. Wherein dataset-II includes 20 molecules and allows selecting tetra-variable models. For a comparative study of QSAR models in either of datasets, we limited variables to tetra-variable models. Descriptors selected in forward selection method fall in similar group of indices which also points out similar structural properties underlying the structure-activity relationship.
Descriptor Sensitivity of Linear QSAR Models
The aim of including two datasets of different chemical origin but targeting the same therapeutic target (AChE) is to study and extract common structure-activity information underlying in QSAR models. In order to achieve comparative SAR, we decided to compare the descriptors sets derived from linear (MLR aided) QSAR models. The contribution of a descriptor (X) in regression equation can be understood when it is multiplied by its coefficient (M). Keeping intercept as constant, we obtained products of descriptors magnitudes multiplied with their coefficients e.g. M1X1, M2X2, M3X3 and M4X4. We have plotted a comparative graph taking Y (Activity) and M1X1, M2X2, M3X3 and M4X4.
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RDF045m impact of activity regulation. Descriptors sensitivity could be an important tool in at least linear QSAR models to evaluate and validate the corresponding contribution of molecular descriptors.
Predictability of QSAR Models
Linear and non-linear QSAR models achieved for dataset-I and dataset-II were found statistically fit and stable. Graphical correlation of predictive powers of QSAR models has been provided below. A straight indication received from graph confirms that SVM aided non-linear QSAR models are statistically fit and more predictive in case of dataset-I and dataset-II. Fig. (3A) represents graphical correlation of experimental pIC 50 and their predicted values from linear QSAR models for dataset-I derived from tetravariable models. Fig. (3B) represents graphical respective values of pIC 50 from SVM aided non-linear QSAR models. The similar aftermath in predictive powers can be observed for dataset-II from tetra-variable models. Fig. (4A) and (4B) presents graphical correlation of experimental and predicted pIC 50 values of dataset-II.
CONCLUSION
Comparative study of MLR aided linear and SVM aided non-linear QSAR models reveals the overlapping SAR required to inhibit AChE targeted in the treatment of Alzheimer's disease. Structure-activity relationship derived from the two different datasets is found to be predominantly regulated by 3D Morse descriptors, which can be clearly observed in all the linear and non-linear QSAR models achieved in present study. Most of the selected 3D Morse descriptors are weighted by their atomic masses which confirms the fact that the distribution of atomic masses in three dimensional spaces is more crucial and not just as an additive structural property. Radial Distribution Function (RDFs) weighted by electronegativity of molecules has also been identified to regulate biological activity of AChE inhibitors. QSAR models have been found to be statistically fit and predictive. The descriptor sensitivity of linear QSAR models could be used to identify the dominant and recessive roles of molecular descriptors selected in multi-variable QSAR models. These overlapping structure-activity relationship can also be utilized to design and synthesize new set of inhibitors for AChE.
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